Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
12.52
-0.72 (-5.44%)
Sep 10, 2026, 1:45 PM CST
SHE:300534 Revenue
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 100.81M CNY in the quarter ending June 30, 2026, a decrease of -51.25%. This brings the company's revenue in the last twelve months to 737.90M, down -24.96% year-over-year. In the year 2025, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 886.96M, down -14.92%.
Revenue (ttm)
737.90M
Revenue Growth
-24.96%
P/S Ratio
5.44
Revenue / Employee
1.15M
Employees
641
Market Cap
4.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.96M | -155.55M | -14.92% |
| Dec 31, 2024 | 1.04B | -37.54M | -3.48% |
| Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
| Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
| Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinling Pharmaceutical Company | 3.18B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Tianjin Lisheng Pharmaceutical | 1.30B |
| Shandong Wohua Pharmaceutical | 784.94M |
| Shanghai Xiao Fang Pharmaceutical | 537.42M |
| Zhongzhu Healthcare Holding Co.,Ltd | 533.88M |
| Sinotherapeutics | 418.12M |